About

Psychedelic Brief is a weekly briefing on European psychedelic medicine, read the way an investor reads it: the deals, the trials, the regulators, and what the contracts actually say.

How it works

Facts go into our database before a word is written. Every claim links to a primary source: a filing, a registry, a regulator. Each issue makes one call that can be proved wrong, with a date, and we score it in public. Misses stay on the record.

What we don't do

No retreats, no supplements, no medical or legal advice.

Who writes it

Dhruv Shekhawat, Berlin. Former VC analyst. dhruv@psychedelicbrief.com